Boehringer’s ‘Breathless Ballad’ sees ‘American Idol’ winner Sparks lend lyrical lift to lung disease campaignnews2021-12-19T20:22:32+00:00December 19th, 2021|Fierce Pharma|
Boehringer’s ‘Breathless Ballad’ sees ‘American Idol’ winner Sparks lend lyrical lift to lung disease campaignnews2021-12-19T20:22:32+00:00December 19th, 2021|Fierce Pharma|
Novavax’s COVID-19 vaccine scores WHO emergency listing, opening up supply to COVAXnews2021-12-17T16:11:20+00:00December 17th, 2021|Fierce Pharma|
Judge knocks back Purdue Pharma’s $4.5B bankruptcy settlementnews2021-12-17T15:00:25+00:00December 17th, 2021|Fierce Pharma|
Eli Lilly enters strike mode ahead of pivotal Alzheimer’s, diabetes launches, CFO saysnews2021-12-17T14:47:53+00:00December 17th, 2021|Fierce Pharma|
Biogen vows to contest EMA rejection of Aduhelm as EU regulators question weak link to Alzheimer’s clinical benefitnews2021-12-17T14:27:15+00:00December 17th, 2021|Fierce Pharma|
2022 forecast: From copywriting to compliance, expect pharma marketers to find new ways to tap AI’s potentialnews2021-12-17T13:42:38+00:00December 17th, 2021|Fierce Pharma|
Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pactnews2021-12-17T12:04:05+00:00December 17th, 2021|Fierce Pharma|
Inozyme rebrand shows the biopharma in a fresher, purple lightnews2021-12-17T11:26:46+00:00December 17th, 2021|Fierce Pharma|
Inozyme rebrand shows the biopharma in a fresher, purple lightnews2021-12-17T11:26:46+00:00December 17th, 2021|Fierce Pharma|
